 | • レポートコード：MRC309Z7923 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の麻疹・おたふく風邪・風疹ウイルス生ワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の麻疹・おたふく風邪・風疹ウイルス生ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 麻疹・おたふく風邪・風疹ウイルス生ワクチンの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 麻疹・おたふく風邪・風疹ウイルス生ワクチン市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・子供、大人 用途別セグメント ・病院、地域 主要な市場プレーヤー ・Merck、Shanghai Institute of Biological Products、Beijing Tiantan Biological Products 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、麻疹・おたふく風邪・風疹ウイルス生ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な麻疹・おたふく風邪・風疹ウイルス生ワクチンメーカーの企業概要、2019年～2022年までの麻疹・おたふく風邪・風疹ウイルス生ワクチンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な麻疹・おたふく風邪・風疹ウイルス生ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別麻疹・おたふく風邪・風疹ウイルス生ワクチンの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの麻疹・おたふく風邪・風疹ウイルス生ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での麻疹・おたふく風邪・風疹ウイルス生ワクチン市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および麻疹・おたふく風邪・風疹ウイルス生ワクチンの産業チェーンを掲載しています。 ・第14、15章では、麻疹・おたふく風邪・風疹ウイルス生ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 麻疹・おたふく風邪・風疹ウイルス生ワクチンの概要 - 種類別分析（2018年vs2022年vs2029年）：子供、大人 - 用途別分析（2018年vs2022年vs2029年）：病院、地域 - 世界の麻疹・おたふく風邪・風疹ウイルス生ワクチン市場規模・予測 - 世界の麻疹・おたふく風邪・風疹ウイルス生ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Merck、Shanghai Institute of Biological Products、Beijing Tiantan Biological Products ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：子供、大人 ・用途別分析2018年-2029年：病院、地域 ・麻疹・おたふく風邪・風疹ウイルス生ワクチンの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・麻疹・おたふく風邪・風疹ウイルス生ワクチンのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・麻疹・おたふく風邪・風疹ウイルス生ワクチンのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・麻疹・おたふく風邪・風疹ウイルス生ワクチンの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・麻疹・おたふく風邪・風疹ウイルス生ワクチンの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Measles, Mumps and Rubella Virus Vaccine Live market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Measles, Mumps and Rubella Virus Vaccine Live is a vaccine against measles, mumps, and rubella (German measles), abbreviated as MMR.
The Global Info Research report includes an overview of the development of the Measles, Mumps and Rubella Virus Vaccine Live industry chain, the market status of Hospital (Child, Adult), Community (Child, Adult), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Measles, Mumps and Rubella Virus Vaccine Live.
Regionally, the report analyzes the Measles, Mumps and Rubella Virus Vaccine Live markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Measles, Mumps and Rubella Virus Vaccine Live market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Measles, Mumps and Rubella Virus Vaccine Live market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Measles, Mumps and Rubella Virus Vaccine Live industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Child, Adult).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Measles, Mumps and Rubella Virus Vaccine Live market.
Regional Analysis: The report involves examining the Measles, Mumps and Rubella Virus Vaccine Live market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Measles, Mumps and Rubella Virus Vaccine Live market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Measles, Mumps and Rubella Virus Vaccine Live:
Company Analysis: Report covers individual Measles, Mumps and Rubella Virus Vaccine Live manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Measles, Mumps and Rubella Virus Vaccine Live This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Community).
Technology Analysis: Report covers specific technologies relevant to Measles, Mumps and Rubella Virus Vaccine Live. It assesses the current state, advancements, and potential future developments in Measles, Mumps and Rubella Virus Vaccine Live areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Measles, Mumps and Rubella Virus Vaccine Live market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Measles, Mumps and Rubella Virus Vaccine Live market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Child
Adult
Market segment by Application
Hospital
Community
Major players covered
Merck
Shanghai Institute of Biological Products
Beijing Tiantan Biological Products
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Measles, Mumps and Rubella Virus Vaccine Live product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Measles, Mumps and Rubella Virus Vaccine Live, with price, sales, revenue and global market share of Measles, Mumps and Rubella Virus Vaccine Live from 2018 to 2023.
Chapter 3, the Measles, Mumps and Rubella Virus Vaccine Live competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measles, Mumps and Rubella Virus Vaccine Live breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Measles, Mumps and Rubella Virus Vaccine Live market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Measles, Mumps and Rubella Virus Vaccine Live.
Chapter 14 and 15, to describe Measles, Mumps and Rubella Virus Vaccine Live sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Measles, Mumps and Rubella Virus Vaccine Live
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Child
1.3.3 Adult
1.4 Market Analysis by Application
1.4.1 Overview: Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Community
1.5 Global Measles, Mumps and Rubella Virus Vaccine Live Market Size & Forecast
1.5.1 Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity (2018-2029)
1.5.3 Global Measles, Mumps and Rubella Virus Vaccine Live Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Measles, Mumps and Rubella Virus Vaccine Live Product and Services
2.1.4 Merck Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Shanghai Institute of Biological Products
2.2.1 Shanghai Institute of Biological Products Details
2.2.2 Shanghai Institute of Biological Products Major Business
2.2.3 Shanghai Institute of Biological Products Measles, Mumps and Rubella Virus Vaccine Live Product and Services
2.2.4 Shanghai Institute of Biological Products Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Shanghai Institute of Biological Products Recent Developments/Updates
2.3 Beijing Tiantan Biological Products
2.3.1 Beijing Tiantan Biological Products Details
2.3.2 Beijing Tiantan Biological Products Major Business
2.3.3 Beijing Tiantan Biological Products Measles, Mumps and Rubella Virus Vaccine Live Product and Services
2.3.4 Beijing Tiantan Biological Products Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Beijing Tiantan Biological Products Recent Developments/Updates
3 Competitive Environment: Measles, Mumps and Rubella Virus Vaccine Live by Manufacturer
3.1 Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Manufacturer (2018-2023)
3.2 Global Measles, Mumps and Rubella Virus Vaccine Live Revenue by Manufacturer (2018-2023)
3.3 Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Measles, Mumps and Rubella Virus Vaccine Live by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Measles, Mumps and Rubella Virus Vaccine Live Manufacturer Market Share in 2022
3.4.2 Top 6 Measles, Mumps and Rubella Virus Vaccine Live Manufacturer Market Share in 2022
3.5 Measles, Mumps and Rubella Virus Vaccine Live Market: Overall Company Footprint Analysis
3.5.1 Measles, Mumps and Rubella Virus Vaccine Live Market: Region Footprint
3.5.2 Measles, Mumps and Rubella Virus Vaccine Live Market: Company Product Type Footprint
3.5.3 Measles, Mumps and Rubella Virus Vaccine Live Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Measles, Mumps and Rubella Virus Vaccine Live Market Size by Region
4.1.1 Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Region (2018-2029)
4.1.2 Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Region (2018-2029)
4.1.3 Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Region (2018-2029)
4.2 North America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018-2029)
4.3 Europe Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018-2029)
4.4 Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018-2029)
4.5 South America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018-2029)
4.6 Middle East and Africa Measles, Mumps and Rubella Virus Vaccine Live Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2029)
5.2 Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Type (2018-2029)
5.3 Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2029)
6.2 Global Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Application (2018-2029)
6.3 Global Measles, Mumps and Rubella Virus Vaccine Live Average Price by Application (2018-2029)
7 North America
7.1 North America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2029)
7.2 North America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2029)
7.3 North America Measles, Mumps and Rubella Virus Vaccine Live Market Size by Country
7.3.1 North America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Country (2018-2029)
7.3.2 North America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2029)
8.2 Europe Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2029)
8.3 Europe Measles, Mumps and Rubella Virus Vaccine Live Market Size by Country
8.3.1 Europe Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Country (2018-2029)
8.3.2 Europe Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Market Size by Region
9.3.1 Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2029)
10.2 South America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2029)
10.3 South America Measles, Mumps and Rubella Virus Vaccine Live Market Size by Country
10.3.1 South America Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Country (2018-2029)
10.3.2 South America Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Market Size by Country
11.3.1 Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Measles, Mumps and Rubella Virus Vaccine Live Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Measles, Mumps and Rubella Virus Vaccine Live Market Drivers
12.2 Measles, Mumps and Rubella Virus Vaccine Live Market Restraints
12.3 Measles, Mumps and Rubella Virus Vaccine Live Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Measles, Mumps and Rubella Virus Vaccine Live and Key Manufacturers
13.2 Manufacturing Costs Percentage of Measles, Mumps and Rubella Virus Vaccine Live
13.3 Measles, Mumps and Rubella Virus Vaccine Live Production Process
13.4 Measles, Mumps and Rubella Virus Vaccine Live Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Measles, Mumps and Rubella Virus Vaccine Live Typical Distributors
14.3 Measles, Mumps and Rubella Virus Vaccine Live Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
